Takeda Pharmaceuticals International AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Takeda Pharmaceuticals International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014028
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Takeda Pharmaceuticals International AG (Takeda), a subsidiary of Takeda Pharmaceutical Company Ltd is a developer, manufacturer and distributor of pharmaceutical products. The company offers treatments in respiratory and immunology, central nervous system, cardiovascular and metabolic, cancer, general medicine, and vaccines areas. Its services include contract manufacturing and product development, product packaging and quality control services. Takeda offers portfolio of patented products, branded generics and over-the-counter products. The company operates in Asia, North America, Europe, and Latin America, among others. Takeda is headquartered in Zurich, Switzerland.

Takeda Pharmaceuticals International AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Takeda Pharmaceuticals International AG, Medical Devices Deals, 2011 to YTD 2017 10
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Nycomed Enters Into Co-Marketing Agreement With Orion For Easyhaler 13
Nycomed Enters Into Co-Marketing Agreement With Almirall 15
Nycomed Enters Into Distribution Agreement With Almirall, Anika, Bionorica, CSL And Helsinn 16
Licensing Agreements 18
Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor 18
Apricus Biosciences Enters Into Licensing Agreement With Takeda Pharma For Vitaros 19
Nycomed Enters Into Licensing Agreement With Almirall For Ebastine 20
Nycomed Enters Into Licensing Agreement With Norgine For MOVIPREP 21
Nycomed Enters Into Licensing Agreement With Orion For Easyhaler 22
Nycomed Enters Into Licensing Agreement With F. Hoffmann-La Roche For Bonviva 23
DURECT Amends Licensing Agreement With Nycomed 24
Eurand Enters Into Licensing Agreement With Nycomed For ZENPEP 26
Equity Offering 27
TiGenix to Raise USD10.4 Million in Private Placement of Shares 27
Acquisition 28
Takeda Pharma Completes Acquisition Of Nycomed International For US$13,681 Million 28
Nycomed Completes Acquisition Of Laboratorios Farmacol 31
Takeda Pharmaceuticals International AG – Key Competitors 32
Takeda Pharmaceuticals International AG – Key Employees 33
Takeda Pharmaceuticals International AG – Locations And Subsidiaries 34
Head Office 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Key Facts 2
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Takeda Pharmaceuticals International AG, Deals By Therapy Area, 2011 to YTD 2017 8
Takeda Pharmaceuticals International AG, Medical Devices Deals, 2011 to YTD 2017 10
Takeda Pharmaceuticals International AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Nycomed Enters Into Co-Marketing Agreement With Orion For Easyhaler 13
Nycomed Enters Into Co-Marketing Agreement With Almirall 15
Nycomed Enters Into Distribution Agreement With Almirall, Anika, Bionorica, CSL And Helsinn 16
Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor 18
Apricus Biosciences Enters Into Licensing Agreement With Takeda Pharma For Vitaros 19
Nycomed Enters Into Licensing Agreement With Almirall For Ebastine 20
Nycomed Enters Into Licensing Agreement With Norgine For MOVIPREP 21
Nycomed Enters Into Licensing Agreement With Orion For Easyhaler 22
Nycomed Enters Into Licensing Agreement With F. Hoffmann-La Roche For Bonviva 23
DURECT Amends Licensing Agreement With Nycomed 24
Eurand Enters Into Licensing Agreement With Nycomed For ZENPEP 26
7 27
Takeda Pharma Completes Acquisition Of Nycomed International For US$13,681 Million 28
Nycomed Completes Acquisition Of Laboratorios Farmacol 31
Takeda Pharmaceuticals International AG, Key Competitors 32
Takeda Pharmaceuticals International AG, Key Employees 33

★海外企業調査レポート[Takeda Pharmaceuticals International AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Premier Marketing Public Company Limited:戦略・SWOT・企業財務分析
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • BrightSpring Health Services:企業の戦略的SWOT分析
    BrightSpring Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Coastal Contacts Inc:医療機器:M&Aディール及び事業提携情報
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International Compagnie Generale d'Optique SA, is an online retailer that markets eye care products. The company provides products such as eyeglasses, contact lenses, sunglasses and vision care accessories, among others. It off …
  • Aibel AS:企業の戦略的SWOT分析
    Aibel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Cisco Systems, Inc (CSCO)-エネルギー分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Future Retail Limited (FRETAIL):企業の財務・戦略的SWOT分析
    Future Retail Limited (FRETAIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • VT Holdings Co Ltd (7593):企業の財務・戦略的SWOT分析
    VT Holdings Co Ltd (7593) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bilfinger SE (GBF)-石油・ガス分野:企業M&A・提携分析
    Summary Bilfinger SE (Bilfinger) is one of the leading global engineering and services companies in the world. It offers a wide range of design, construction, maintenance, engineering, consulting, and project management services across diverse end markets. The company’s major service offerings inclu …
  • Shri Lakshmi Cotsyn Ltd.:企業の戦略・SWOT・財務情報
    Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hogan Lovells International LLP:企業の戦略的SWOT分析
    Hogan Lovells International LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Tepha Inc:企業の製品パイプライン分析
    Summary Tepha Inc (Tepha) is a medical device firm that develops and commercializes biomaterial technology products. The firm offers products such as absorbable monofilament suture, absorbable monofilament mesh, composite mesh and absorbable surgical film. It also provides platforms including absorb …
  • Origin Enterprises PLC:企業のM&A・事業提携・投資動向
    Origin Enterprises PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Origin Enterprises PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • ARMO Biosciences Inc (ARMO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARMO Biosciences Inc (ARMO Biosciences) is an immuno-oncology company that develops tumors treatment drugs. Its pipeline drug candidates include AM0010, AM0015, AM0012, AM0003 and AM0001. ARMO Biosciences’s lead immunotherapy AM0010 is along-acting form of recombinant human Interleukin 10 (I …
  • Xeikon N.V.:企業の戦略的SWOT分析
    Xeikon N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sumitomo Seika Chemicals Co Ltd (4008):企業の財務・戦略的SWOT分析
    Sumitomo Seika Chemicals Co Ltd (4008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Opthea Ltd (OPT):企業の財務・戦略的SWOT分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • Alliance Healthcare Services Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alliance Healthcare Services Inc (Alliance Healthcare Services) is a provider of outsourced services including diagnostic imaging services. It provides a full line of services ranging from systems, technologists to operate the systems, sales and marketing, patient scheduling and pre-authoriz …
  • Manchester United Plc:企業の戦略・SWOT・財務分析
    Manchester United Plc - Strategy, SWOT and Corporate Finance Report Summary Manchester United Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ferguson Plc:企業の戦略・SWOT・財務分析
    Ferguson Plc - Strategy, SWOT and Corporate Finance Report Summary Ferguson Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆